Market Overview The global pancreatic cancer market was valued at USD 2.32 billion in 2021 and is expected to grow at a CAGR of 13.8% during the forecast period.  Pancreatic cancer is one of the most aggressive malignancies with a historically low 5‑year survival rate, largely due to late diagnosis and rapid progression. The market includes diagnostics (imaging, molecular biomarkers),...